ERBB2 and breast cancer: Since the addition of physiological concentrations of exogenous saturated fatty acids, such as palmitate, induces cell death in HER2/neu-positive breast cancer cells at significantly lower concentrations than in other breast cancer cells or normal human mammary epithelial cells (HMECs) [7], the lipogenic pathway is likely operating at maximum capacity in these cells.